<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR57">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Chou</surname>
    <given-names>A-H</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Y-L</given-names>
   </name>
   <name>
    <surname>Chiu</surname>
    <given-names>C-C</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>S-J</given-names>
   </name>
   <name>
    <surname>Weng</surname>
    <given-names>Y-H</given-names>
   </name>
   <name>
    <surname>Yeh</surname>
    <given-names>T-H</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Y-L</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>J-M</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H-L</given-names>
   </name>
  </person-group>
  <article-title>T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and symptoms of ataxia in the SCA3 transgenic mouse</article-title>
  <source>Neuropharmacology</source>
  <year>2015</year>
  <volume>99</volume>
  <fpage>308</fpage>
  <lpage>317</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.08.009</pub-id>
  <?supplied-pmid 26254860?>
  <pub-id pub-id-type="pmid">26254860</pub-id>
 </element-citation>
</ref>
